Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.
about
BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles.Health-state utility estimates for health technology assessment: a review of the manufacturers' submissions to the French National Authority for Health.Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).Towards a New Framework for Addressing Structural Uncertainty in Health Technology Assessment Guidelines.The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges.
P2860
Exploring Uncertainty in Economic Evaluations of Drugs and Medical Devices: Lessons from the First Review of Manufacturers' Submissions to the French National Authority for Health.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Exploring Uncertainty in Econo ...... National Authority for Health.
@en
type
label
Exploring Uncertainty in Econo ...... National Authority for Health.
@en
prefLabel
Exploring Uncertainty in Econo ...... National Authority for Health.
@en
P2093
P2860
P1433
P1476
Exploring Uncertainty in Econo ...... National Authority for Health.
@en
P2093
Françoise F Hamers
Jean Michel Josselin
Salah Ghabri
P2860
P2888
P304
P356
10.1007/S40273-016-0381-4
P577
2016-01-30T00:00:00Z